Return to List

Study Summary
No. 2008-0853:.......Colorectum; Lung......Osama R Mawlawi......Imaging Physics
.
Study Summary Title
Study Summary
Number:
2008-0853
Study Title:4D PET/CT Imaging in Lung and Colorectal Cancer with Liver Metastasis
.
Physician New Patient Referral
Name:Osama R MawlawiPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Imaging PhysicsReferring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-563-2711
Contact us about clinical trials
.
General Information
Disease Group:Colorectum
Lung
Supported By:General Electric Healthcare
Phase of Study:N/AReturn
Visit:
N/A
Treatment
Agents:
NoneHome Care:N/A
Treatment Loc:Only at MDACC
Estimated
Length of Stay
in Houston:
N/A
Description/
Intervention:
The goal of this clinical research study is to learn if adjusting the PET/CT
scanner to allow for breathing motion can improve the quality of PET/CT images.
.
Study Objectives / Outcomes
The objective of this proposal is to study the impact of 4D Positron Emission Tomography/Computed Tomography (PET/CT) imaging on the evaluation and staging of lung and colorectal cancer.

This research project has three goals:
      1. Acquire 4D PET/CT data on 26 lung and/or colorectal patients with specific inclusion criteria.
      2. Compare lesion SUVmax between gated and non-gated PET scans.
3. Evaluate the impact of the difference in the maximum standardized uptake value (SUVmax) on
lesion detectability and staging.
.
Study Status Information
Study Activation / Registration Date:03/12/2009
IRB Review and Approval Date:02/05/2009
Study Type:Other
Recruitment Status:Open
Projected Accrual:N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:1) Patients with suspected colorectal cancer with nodules in the lung or liver (1-2 cm in diameter) will be eligible for this study.

2) Patients with suspected lung cancer with nodules in the lung or liver (1-2 cm in diameter) will be eligible for this study.

Exclusion Criteria:1) Pediatric patients (younger than 18 years) will be excluded.

2) Patients that cannot tolerate being scanned for an additional 12 minutes with arms above their head will be excluded.

.
Links
Registration Number: NCT00862680
Study Information on Clinical Trials Registry (clinicaltrials.gov)

Other Links:
.
Results


Return to Clinical Trials at M.D. Anderson Cancer Center